Ratings by Rodman & Renshaw (Brandon Folkes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2025 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2025 | Trevi Therapeutics | TRVI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2025 | Adial Pharmaceuticals Inc | ADIL | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2025 | Cardiol Therapeutics | CRDL | New Coverage | Buy (N/A) |
1.29 (1.27) |
-1.55% | Details | |
| 1/28/2025 | Indivior | INDV | New Coverage | Buy (N/A) |
12.02 (40.01) |
232.86% | Details | |
| 1/28/2025 | Rein Therapeutics | RNTX | New Coverage | Buy (N/A) |
2.10 (0.74) |
-64.76% | Details | |
| 1/28/2025 | PolyPid Ltd. | PYPD | New Coverage | Buy (N/A) |
3.15 (4.29) |
36.19% | Details | |
| 1/28/2025 | Talphera | TLPH | New Coverage | Buy (N/A) |
0.72 (1.28) |
77.78% | Details | |
| 11/14/2024 | Rockwell Medical Technologies | RMTI | New Coverage | Buy (N/A) |
2.63 (7.19) |
173.38% | Details | |
| 11/14/2024 | Eupraxia Pharmaceuticals | EPRX | New Coverage | Buy (N/A) |
2.84 (6.40) |
125.35% | Details | |
| 11/14/2024 | Achieve Life Sciences | ACHV | New Coverage | Buy (N/A) |
4.53 (6.42) |
41.72% | Details | |
| 11/14/2024 | Adial Pharmaceuticals Inc | ADIL | New Coverage | Buy (N/A) |
0.99 (3.34) |
237.37% | Details | |
| 11/14/2024 | Omeros Corp. | OMER | New Coverage | Buy (N/A) |
4.19 (11.84) |
182.58% | Details | |
| 8/26/2024 | CorMedix | CRMD | New Coverage | Buy (N/A) |
5.65 (7.53) |
33.27% | Details | |
| 6/13/2024 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
2.60 (18.25) |
601.92% | Details | |
| 6/13/2024 | Scilex Holding Co. | SCLX | New Coverage | Buy (N/A) |
1.33 (6.67) |
401.5% | Details | |
| 6/13/2024 | Heron Therapeutics | HRTX | New Coverage | Buy (N/A) |
3.64 (0.50) |
-86.26% | Details | |
| 6/13/2024 | Rani Therapeutics Holdsing s | RANI | New Coverage | Buy (N/A) |
4.01 (0.77) |
-80.8% | Details | |
| 6/13/2024 | MannKind | MNKD | New Coverage | Buy (N/A) |
4.65 (3.91) |
-15.91% | Details |
